Home›Stock Screener›Nureca›Quarterly Results

Nureca Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹-6 Cr
QMar 2026
Quarterly Results

In Mar 2026, Nureca (NURECA) reported revenue ₹36 Cr and net profit ₹-6 Cr — revenue +5.9% YoY. View NURECA price range for the annual high/low range and current price position.

NURECA Quarterly Results — Revenue, Profit & EPS Highlights

Nureca latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Nureca share price chart.

  • Revenue of ₹36 Cr in Mar 2026 (-14.3% vs Jun 2026, +5.9% vs Mar 2025)
  • Net Profit of ₹-6 Cr in Mar 2026 (-300.0% vs Jun 2026, -300.0% vs Mar 2025)
  • EBITDA of ₹-5 Cr in Mar 2026 (-200.0% vs Jun 2026)
  • Operating Margin of -16.0% in Mar 2026 (-24.0pp vs Jun 2026)
  • Earnings Per Share of ₹-6.45 in Mar 2026 (-300.9% vs Jun 2026)

Nureca Quarterly Results — Revenue, EBITDA, Net Profit & EPS

NURECA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 36 42 40 34 37 -14.3% 5.9%
Net Profit (₹ Cr) -6 3 4 3 1 - -
EBITDA (₹ Cr) -5 5 6 3 2 - -
EPS (₹) -6.45 3.21 3.63 2.47 0.81 - -
Operating Margin (%) -16.0% 8.0% 9.0% 4.0% -2.0% - -

NURECA Share Price Trend — 1-Year Movement Across Quarterly Results

Nureca 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse Nureca ownership pattern to track promoter, FII and institutional holdings.

Profitability Ratios

Profit Margin -16.7%
EBITDA Margin -13.9%
Operating Margin -16.0%
ROE (Annual) -13.3%

Balance Sheet Highlights

Total Assets ₹196 Cr
Total Equity ₹181 Cr
Current Assets ₹115 Cr
Current Liabilities ₹2 Cr

Cash Flow Analysis

Operating Cash Flow ₹3 Cr
Investing Cash Flow ₹15 Cr
Financing Cash Flow ₹-20 Cr
Net Cash Flow ₹-2 Cr

Current Market Data

Current Price ₹342.60
Exchange NSE
Last Updated Aug 07, 2026

Revenue Trend (₹ Cr)

Mar 2025 34
Sept 2025 40
Jun 2026 42
Mar 2026 36

Net Profit Trend (₹ Cr)

Mar 2025 3
Sept 2025 4
Jun 2026 3
Mar 2026 -6

Operating Margin Trend (%)

Mar 2025 4.0%
Sept 2025 9.0%
Jun 2026 8.0%
Mar 2026 -16.0%

NURECA vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Nureca latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹441,477.63 Cr 1837.3 15,018 2,710 -5.6% - 18.0% 162.6
Divis Laboratories
Mar 2026 		₹247,469.81 Cr 9375.0 2,986 751 -5.0% - 25.2% 331.2
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4840.0 4,111 364 +27.7% +42.2% 8.9% 420.5
Cipla
Mar 2026 		₹112,654.03 Cr 1394.5 6,612 543 -9.3% - 8.2% 203.0
Zydus Life Science
Mar 2026 		₹112,607.65 Cr 1160.0 7,569 1,341 -4.3% - 17.7% 91.7
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores